Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

Share Price is delayed by 15 minutes
Get Live Data
49.00    0.00 (0.00%)
Bid:
48.00
Ask:
50.00
Spread: 2.00 (4.167%)
Market Cap: £35.50m
PCIP Live PriceLast checked at - London Stock Exchange

Intraday Pci-pal Share Chart

HIPAA, HITRUST & SOC 2 Type II certification

14 Apr 2026 07:00

RNS Number : 2462A
PCI-PAL PLC
14 April 2026
 

 

 

Reach - Non-Regulatory Announcement

 

14 April 2026

 

PCI-PAL PLC

("PCI Pal", "the Group", or the "Company")

 

Achievement of HIPAA, HITRUST, and SOC 2 Type II certification

 

PCI-PAL PLC (AIM: PCIP), the global cloud provider of secure payment solutions for business communications, is pleased to announce that it has successfully achieved HIPAA, HITRUST and SOC 2 Type II compliance, enhancing its ability to support enterprise customers operating in highly regulated environments, particularly in the United States.

 

HIPAA (Health Insurance Portability and Accountability Act) is the key US healthcare data protection regulation, imposing strict security and privacy requirements on organisations handling sensitive patient information across the healthcare industry.

 

HITRUST is a leading certifiable security framework in the US healthcare sector, providing a comprehensive and auditable approach to managing data protection, privacy and regulatory compliance, and is often used to demonstrate alignment with HIPAA requirements.

 

SOC 2 Type II is a widely recognised and adopted independent audit standard in the US, validating that strong security and data protection controls are operating effectively over time, and is commonly expected by enterprise customers in the US.

 

Combined these achievements are exceptional in the Company's industry and reflect PCI Pal's continued commitment to maintaining the highest levels of data security, privacy, and regulatory compliance for not only its customers, but also in supporting its partners many of whom operate extensively across the US enterprise space.

 

Commenting, James Barham, Chief Executive Officer of PCI Pal, said:

 

"Achieving HIPAA and HITRUST audited compliance, alongside our successful SOC 2 Type II attestation, is an important milestone for PCI Pal. It underscores our continued investment in robust and regulated security frameworks, which is supporting enhanced competitive differentiation and positioning for the Company, as well as building additional customer trust. Together, they provide our customers with independently validated assurance in our ability to meet rigorous compliance requirements while delivering secure, reliable, enterprise-grade cloud solutions.

 

"For our partners, these achievements further strengthen an already comprehensive compliance and security foundation across the PCI Pal cloud platform. They also reinforce the basis for mutual growth across both human and AI engagement environments, as we continue to deliver incremental value and deepen strategic relationships.

 

"With expansion across enterprise customers in the US a key strategic goal, these standards further enhance our ability to engage with large, regulated organisations and position PCI Pal to capitalise on its significant market opportunity at pace."

 

 

For further information, please contact:

 

PCI-PAL PLC

Via Walbrook PR

James Barham - Chief Executive Officer

Ryan Murray - Chief Financial Officer

 

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

+44 (0) 20 7227 0500

Marc Milmo/ Fergus Sullivan (Corporate Finance)

Sunila De Silva (Corporate Broking)

 

Walbrook PR

+44 (0) 20 7933 8780

Tom Cooper/Nick Rome

+44 (0) 797 122 1972

tom.cooper@walbrookpr.com

 

 

About PCI Pal:

 

PCI Pal is a leading provider of secure, cloud-based payment and data protection solutions that enable organisations to take frictionless, compliant payments seamlessly integrated to any business communications environment including voice, chat, messaging, social media, and email. PCI Pal's platform supports all forms of customer engagement, whether human-to-human or AI-driven conversations.

 

PCI Pal has an extensive partner eco-system with its products resold by many of the world's leading Communications, CCaaS, and UCaaS vendors. Its platform integrates with a broad range of digital payment methods and connects to the majority of leading payment service providers globally.

 

For more information visit www.pcipal.com or follow the team on LinkedIn: https://www.linkedin.com/company/pci-pal/

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAXXLFFQZLBBBF
Date   Source Headline
14th Apr 20267:00 amRNS-RHIPAA, HITRUST & SOC 2 Type II certification
18th Mar 20267:00 amRNS-RMajor New Reseller Partnership with Global Telco
10th Mar 20263:07 pmRNSHolding(s) in Company
10th Mar 20263:07 pmRNSHolding(s) in Company
3rd Mar 20267:00 amRNSInterim Results, Analyst Briefing & Investor Pres
23rd Feb 20267:00 amRNS-RNew Major Strategic Reseller Partnership
17th Feb 20267:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
10th Feb 20265:07 pmRNSHolding(s) in Company
6th Feb 202611:26 amRNSHolding(s) in Company
6th Feb 202611:25 amRNSHolding(s) in Company
5th Feb 202612:48 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSTrading Update
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
1st Dec 20252:49 pmRNSResult of AGM
19th Nov 20257:00 amRNS-RStrategic US Healthcare Sector Integration
17th Nov 20253:19 pmRNS-RCMD Presentation Video
14th Nov 20257:00 amRNS-RCMD Presentation & MelloLondon
11th Nov 20257:00 amRNSCapital Markets Day
6th Nov 20254:20 pmRNSAnnual Financial Report & Notice of AGM
25th Sep 20258:45 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
19th Aug 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
30th Jul 20253:18 pmRNSDirector Share Purchases
29th Jul 202510:20 amRNSDirector Share Purchase
29th Jul 20257:01 amRNSTrading & Business Update
29th Jul 20257:00 amRNSNew Product Launch
1st Jul 20257:00 amRNSBoard Changes
20th Jun 202512:00 pmRNSIssue of Equity & TVR
3rd Apr 20259:24 amRNSHolding(s) in Company
12th Mar 20253:20 pmRNSDirector Share Purchases
10th Mar 20257:00 amRNS-RPCI Pal and RingCentral Inc Partnership
6th Mar 20252:00 pmRNSPDMR Issue of Options
4th Mar 20253:49 pmRNSDirector Share Purchase
4th Mar 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
18th Feb 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
27th Jan 20257:00 amRNSTrading Update
11th Dec 20242:42 pmRNSHolding(s) in Company
11th Dec 20242:17 pmRNSResult of AGM
11th Dec 20247:00 amRNSAGM Statement
6th Dec 20244:10 pmRNSExercise of Options & TVR
14th Nov 20244:23 pmRNSAnnual Financial Report & Notice of AGM
22nd Oct 20247:00 amRNSFinal Results, Analyst Briefing & Investor Pres
14th Oct 20247:00 amRNSConfirmation of CFO Appointment
19th Sep 20247:00 amRNSAudit Update & Timing of Results
10th Sep 20244:46 pmRNSHolding(s) in Company
28th Aug 20247:00 amRNSTrading Update, New Partner & Notice of Results
22nd Jul 20249:15 amRNSHolding(s) in Company
1st Jul 20245:23 pmRNSExercise of Options, Director Shareholding & TVR
1st Jul 20247:00 amRNSBoard Changes - Appointment of CFO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.